Unknown

Dataset Information

Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer's continuum.


ABSTRACT:

Purpose

Glial activation is one of the earliest mechanisms to be altered in Alzheimer's disease (AD). Glial fibrillary acidic protein (GFAP) relates to reactive astrogliosis and can be measured in both cerebrospinal fluid (CSF) and blood. Plasma GFAP has been suggested to become altered earlier in AD than its CSF counterpart. Although astrocytes consume approximately half of the glucose-derived energy in the brain, the relationship between reactive astrogliosis and cerebral glucose metabolism is poorly understood. Here, we aimed to investigate the association between fluorodeoxyglucose ([18F]FDG) uptake and reactive astrogliosis, by means of GFAP quantified in both plasma and CSF for the same participants.

Methods

We included 314 cognitively unimpaired participant

SUBMITTER: Salvado G 

PROVIDER: S-EPMC9606048 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature